As a result of the global SARS-CoV-2pandemic, clinical microbiology laboratories are facing a significantly increased workload. On top of testing for the virus, those critically ill with COVID-19 are susceptible to secondary bacterial infections.
Bruker’s MALDI Biotyper can be implemented with the MBT Sepsityper IVD Kit, enabling reliable species identification directly from positive blood cultures in 15–20 minutes.
“The Sepsityper solution has revolutionised diagnostic microbiology in our laboratory. With rapid identification of a blood culture flagging positive, we are able to change treatment and management properly, escalating or de-escalating as appropriate. Reducing the time to identification means we are able to improve patient outcomes dramatically, and the Sepsityper has not only improved clinical outcomes but diagnostic practice as well,” says Francis Yongblah, Laboratory Manager and HSST Clinical Scientist.
www.bruker.com
